ゲノム編集の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR2540)
◆英語タイトル:Global Genome Editing Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2540
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、ゲノム編集の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(CRISPR、TALEN、ZFN)、用途別市場規模(細胞株工学、動物遺伝子工学、植物遺伝子工学)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・ゲノム編集の市場動向
・企業の競争状況、市場シェア
・ゲノム編集の種類別市場規模(CRISPR、TALEN、ZFN)
・ゲノム編集の用途別市場規模(細胞株工学、動物遺伝子工学、植物遺伝子工学)
・ゲノム編集の北米市場規模2016-2027(アメリカ、カナダ)
・ゲノム編集の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・ゲノム編集のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ゲノム編集の中南米市場規模2016-2027(メキシコ、ブラジル)
・ゲノム編集の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Genscript、Horizon Discovery Group、Lonza、Merck KGaA、Sangamo Therapeutics、Thermo Fisher Scientific)
・結論
【レポートの概要】

Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or “molecular scissors”. These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.
The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years. With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years. According to CDC, there were about 1.8 million new cases of HIV reported in 2016. Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients. Consequently, the rise in prevalence of such ailments will impact the demand for novel therapies equipping several genome editing tools in the forthcoming years.

Market Analysis and Insights: Global Genome Editing Market
The global Genome Editing market size is projected to reach US$ 6166.3 million by 2026, from US$ 3291.6 million in 2019, at a CAGR of 9.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genome Editing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genome Editing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genome Editing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genome Editing market.

Global Genome Editing Scope and Market Size
Genome Editing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genome Editing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CRISPR
TALEN
ZFN

Segment by Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genscript
Horizon Discovery Group
Lonza
Merck KGaA
Sangamo Therapeutics
Thermo Fisher Scientific

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Editing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CRISPR
1.2.3 TALEN
1.2.4 ZFN
1.3 Market by Application
1.3.1 Global Genome Editing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Genome Editing Market Perspective (2016-2027)
2.2 Genome Editing Growth Trends by Regions
2.2.1 Genome Editing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genome Editing Historic Market Share by Regions (2016-2021)
2.2.3 Genome Editing Forecasted Market Size by Regions (2022-2027)
2.3 Genome Editing Industry Dynamic
2.3.1 Genome Editing Market Trends
2.3.2 Genome Editing Market Drivers
2.3.3 Genome Editing Market Challenges
2.3.4 Genome Editing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Genome Editing Players by Revenue
3.1.1 Global Top Genome Editing Players by Revenue (2016-2021)
3.1.2 Global Genome Editing Revenue Market Share by Players (2016-2021)
3.2 Global Genome Editing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genome Editing Revenue
3.4 Global Genome Editing Market Concentration Ratio
3.4.1 Global Genome Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Editing Revenue in 2020
3.5 Genome Editing Key Players Head office and Area Served
3.6 Key Players Genome Editing Product Solution and Service
3.7 Date of Enter into Genome Editing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Genome Editing Breakdown Data by Type
4.1 Global Genome Editing Historic Market Size by Type (2016-2021)
4.2 Global Genome Editing Forecasted Market Size by Type (2022-2027)

5 Genome Editing Breakdown Data by Application
5.1 Global Genome Editing Historic Market Size by Application (2016-2021)
5.2 Global Genome Editing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Genome Editing Market Size (2016-2027)
6.2 North America Genome Editing Market Size by Type
6.2.1 North America Genome Editing Market Size by Type (2016-2021)
6.2.2 North America Genome Editing Market Size by Type (2022-2027)
6.2.3 North America Genome Editing Market Size by Type (2016-2027)
6.3 North America Genome Editing Market Size by Application
6.3.1 North America Genome Editing Market Size by Application (2016-2021)
6.3.2 North America Genome Editing Market Size by Application (2022-2027)
6.3.3 North America Genome Editing Market Size by Application (2016-2027)
6.4 North America Genome Editing Market Size by Country
6.4.1 North America Genome Editing Market Size by Country (2016-2021)
6.4.2 North America Genome Editing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Genome Editing Market Size (2016-2027)
7.2 Europe Genome Editing Market Size by Type
7.2.1 Europe Genome Editing Market Size by Type (2016-2021)
7.2.2 Europe Genome Editing Market Size by Type (2022-2027)
7.2.3 Europe Genome Editing Market Size by Type (2016-2027)
7.3 Europe Genome Editing Market Size by Application
7.3.1 Europe Genome Editing Market Size by Application (2016-2021)
7.3.2 Europe Genome Editing Market Size by Application (2022-2027)
7.3.3 Europe Genome Editing Market Size by Application (2016-2027)
7.4 Europe Genome Editing Market Size by Country
7.4.1 Europe Genome Editing Market Size by Country (2016-2021)
7.4.2 Europe Genome Editing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Genome Editing Market Size (2016-2027)
8.2 Asia-Pacific Genome Editing Market Size by Type
8.2.1 Asia-Pacific Genome Editing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genome Editing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genome Editing Market Size by Type (2016-2027)
8.3 Asia-Pacific Genome Editing Market Size by Application
8.3.1 Asia-Pacific Genome Editing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genome Editing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genome Editing Market Size by Application (2016-2027)
8.4 Asia-Pacific Genome Editing Market Size by Region
8.4.1 Asia-Pacific Genome Editing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genome Editing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Genome Editing Market Size (2016-2027)
9.2 Latin America Genome Editing Market Size by Type
9.2.1 Latin America Genome Editing Market Size by Type (2016-2021)
9.2.2 Latin America Genome Editing Market Size by Type (2022-2027)
9.2.3 Latin America Genome Editing Market Size by Type (2016-2027)
9.3 Latin America Genome Editing Market Size by Application
9.3.1 Latin America Genome Editing Market Size by Application (2016-2021)
9.3.2 Latin America Genome Editing Market Size by Application (2022-2027)
9.3.3 Latin America Genome Editing Market Size by Application (2016-2027)
9.4 Latin America Genome Editing Market Size by Country
9.4.1 Latin America Genome Editing Market Size by Country (2016-2021)
9.4.2 Latin America Genome Editing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Genome Editing Market Size (2016-2027)
10.2 Middle East & Africa Genome Editing Market Size by Type
10.2.1 Middle East & Africa Genome Editing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genome Editing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genome Editing Market Size by Type (2016-2027)
10.3 Middle East & Africa Genome Editing Market Size by Application
10.3.1 Middle East & Africa Genome Editing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genome Editing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genome Editing Market Size by Application (2016-2027)
10.4 Middle East & Africa Genome Editing Market Size by Country
10.4.1 Middle East & Africa Genome Editing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genome Editing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genscript
11.1.1 Genscript Company Details
11.1.2 Genscript Business Overview
11.1.3 Genscript Genome Editing Introduction
11.1.4 Genscript Revenue in Genome Editing Business (2016-2021)
11.1.5 Genscript Recent Development
11.2 Horizon Discovery Group
11.2.1 Horizon Discovery Group Company Details
11.2.2 Horizon Discovery Group Business Overview
11.2.3 Horizon Discovery Group Genome Editing Introduction
11.2.4 Horizon Discovery Group Revenue in Genome Editing Business (2016-2021)
11.2.5 Horizon Discovery Group Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Genome Editing Introduction
11.3.4 Lonza Revenue in Genome Editing Business (2016-2021)
11.3.5 Lonza Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Genome Editing Introduction
11.4.4 Merck KGaA Revenue in Genome Editing Business (2016-2021)
11.4.5 Merck KGaA Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics Genome Editing Introduction
11.5.4 Sangamo Therapeutics Revenue in Genome Editing Business (2016-2021)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Genome Editing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Genome Editing Business (2016-2021)
11.6.5 Thermo Fisher Scientific Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ゲノム編集の世界市場規模・現状・予測2021年-2027年(Global Genome Editing Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。